Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Clinical Genitourinary Cancer|March 11, 2025
Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart ReviewGirish S Kulkarni, Thomas Guzzo, Philip H Abbosh, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 4, 2024
A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder CancerJoep J de Jong, Florus C de Jong, Angelique C J van der Made, et al.
Cancer Immunology, Immunotherapy : CII|August 17, 2022
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancerMaud Rijnders, Debbie G J Robbrecht, Astrid A M Oostvogels, et al.
The Journal of Urology|October 13, 2021
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant ChemotherapyYair Lotan, Joep J de Jong, Vinnie Y T Liu, et al.
The Journal of Urology|October 18, 2016
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for CystoscopyKim E M van Kessel, Willemien Beukers, Irene Lurkin, et al.
Urologic Oncology|March 3, 2018
Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer networkTahlita C M Zuiverloon, Kim E M van Kessel, Trinity J Bivalacqua, et al.
The Journal of Pathology. Clinical Research|March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testingMiriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
Cancer Research|September 17, 2008
Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancerKarin G Hermans, Hetty A van der Korput, Ronald van Marion, et al.
Urologic Oncology|April 17, 2018
Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomyBrian R Winters, Funda Vakar-Lopez, Lisha Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide StudyKatharina Brück, Richard P Meijer, Joost L Boormans, et al.
Pageof 11